Press - MIG Verwaltung EN

Capital Heft Dezember - Tue, 06. December 2016

Top 40 under 40

The economic journal “Capital” runs a cover story on Germany’s young elite featuring Andreas Kunze, CEO of MIG portfolio company Konux.

Süddeutsche Zeitung - Wed, 16. November 2016

Funds for founders

Michael Motschmann, General Partner and member of the Executive Board at MIG AG, is quoted several times in an article by the Süddeutsche Zeitung on the funding options for start-up companies.

Handelsblatt - Wed, 02. November 2016

German biotechnology: foreign companies want in

The Handelsblatt has published an article shedding some light on the sale of MIG portfolio company Ganymed to Japanese pharmaceutical company Astellas. MIG is named as the venture capitalist.

Handelsblatt - Tue, 01. November 2016

Digital prize "The Spark" – More guts will do you good

Handelsblatt and McKinsey have awarded Konus and NaVvis, two portfolio companies of MIG Fonds, with the digital prize “The Spark” for innovations in industry 4.0.

Find out more

Euro am Sonntag - Sun, 09. October 2016

We’re at the beginning of an era

Jürgen Eck, CEO of BRAIN AG, a MIG portfolio company, explains why he believes the trend for natural solutions in the chemical and consumer goods industry will keep on growing and growing.

Handelsblatt - Sat, 01. October 2016

Efficient Energy - cool stuff

Handelsblatt presents Efficient Energy, a MIG portfolio company, and describes their new refrigeration technology as an innovative breakthrough. MIG Fonds are named as venture capitalists.

Find out more

F.A.S. - Sun, 25. September 2016

Millions from California for the biotech pioneers from Mainz

Frankfurter Allgemeine Sonntagszeitung publishes an article about partnership between BioNTech, a MIG portfolio company, and the pharmaceutical company Genentech. Genentech has made an upfront payment of 310 million dollars to BioNTech.

Fierce Biotech - Wed, 21. September 2016

Genentech lays $310M wager on BioNTech’s mRNA cancer vaccine platform

The trade journal FierceBiotech outlines the newest deal involving the payment of 310 million USD to MIG portfolio company BioNTech from Roche’s affiliated company Genentech.

Find out more

EP Vantage - Wed, 21. September 2016

Biontech deal sees Roche bet on mRNA

The article by EP Vantage covers the latest partnership entered into by MIG portfolio company BioNTech aiming to advance developments of mRNA-based cancer vaccines. The pharmaceutical group Roche is also in on the latest deal.

Find out more

VC Magazin - Wed, 31. August 2016

Interview with Michael Motschmann and Dr. Matthias Kromayer

The two MIG AG Executive Board members comment to recent successful exits, flotation of MIG portfolio company BRAIN and their next strategical moves with Venture Capital Magazin.

Harvard Business Manager - Tue, 30. August 2016

Inspiration in instalments

For a case study conducted by Harvard Business Manager, Dr. Matthias Kromayer, member of the Executive Board at MIG AG, discusses three principles of strategic company management.

Frankfurter Allgemeine Sonntagszeitung - Sun, 21. August 2016

The dream team of the biotech industry

Frankfurter Allgemeine Sonntagszeitung presents Özlem Türeci and Ugur Sahin, CEOs of Ganymed and BioNTech respectively. Both companies belong to the MIG portfolio.

Süddeutsche Zeitung - Fri, 22. July 2016

Playing with your own money “kills your ego”

Profile of the MIG portfolio company Konux and its co-founder Andreas Kunze.

Find out more

Fierce Biotech - Sun, 05. June 2016

Billionaire-backed Ganymed grabs ASCO spotlight

The renowned trade journal FierceBiotech reports on ASCO, the largest oncology congress in the world. MIG portfolio company Ganymed is one of the stars of the show with their new phase 2b trial.

Find out more

Wirtschaftswoche - Wed, 01. June 2016

First universal cancer vaccine within reach

The article outlines MIG portfolio company BioNTech’s ground-breaking progress in the fight against cancer.

Find out more

FAZ - Mon, 23. May 2016

Off through the museum with a ‘data hoover’

FAZ has published a detailed article discussing how the 3D trolley developed by NavVis, an MIG portfolio company, captures and maps interior spaces.

Find out more

Handelsblatt - Fri, 29. April 2016

Start-up company Konux – the defect detector

Smart sensors and prominent investors: MIG portfolio company Konux wants to revolutionise the untended German industry by helping to eliminate faults before they even occur.

Find out more

Finanzwelt - Fri, 15. April 2016

An addition to the MIG Fonds portfolio

Finanzwelt talks about MIG Fonds‘ acquisition of a 16.26 % share in Konux Inc in a series A round, making Konux the youngest company in MIG’s portfolio.

Find out more

Focus Online - Mon, 11. April 2016

China stumps up billions for German entrepreneurs

Heinrich von Pierer describes the latest trend, whereby Chinese sovereign wealth funds are ending up in Germany as venture capitalist funds – a development which can even create opportunities for MIG.

Find out more

Handelsblatt - Wed, 16. March 2016

Cancer vaccines

Handelsblatt presents Biontech as an inspiring start-up business in the biotech sector in a full-page profile, making several references to MIG Fonds as the participating VC investor.

Süddeutsche Zeitung - Thu, 03. March 2016

One number, a worldwide connection

SZ features an article outlining the wide-reaching scope of the collaboration between Nfon, an MIG portfolio company, and German Telekom in developing cloud-based telephone systems.

Find out more

Manager Magazin - Tue, 23. February 2016

A new Germany

NavVis, an MIG portfolio company, took pride of place as one of the hidden champions in an article listing over 50 successful digital business models.

Find out more

Handelsblatt - Wed, 27. January 2016

Indoor satnavs

Handelsblatt has published an extensive profile on NavVis, citing MIG AG as a key VC investor who has been channeling money into the up-and-coming business since 2014.

Börsen-Zeitung - Fri, 22. January 2016

Brain risks IPO despite the storm raging on the stock market

The response to being given the go-ahead for an IPO was obviously so good that the biotech firm Brain wants to follow through with its first steps onto the capital market despite the storm that’s currently raging.

Focus Online - Tue, 19. January 2016

Technological company Brain goes public

Dr. Heinrich von Pierer has written an article explaining what consequences the IPO of Brain AG, an MIG Fonds portfolio company, will have for the German start-up business scene.

Find out more

DLD - Mon, 18. January 2016

Jury awards top-class prize to NavVis

This year, the internationally renowned DLD prize “Digital Star” goes to NavVis, an MIG Fonds portfolio company. The start-up company from Munich won the main prize entitled “Innovation of the Year”.

Börsen-Zeitung - Wed, 06. January 2016

When Microorganisms solve problems

Börsen-Zeitung sheds some light on Brain AG’s business model, as well as their plans for the stock market. The article names MIG as an essential investor.

MIG - Press Review

2016

Top 40 under 40

The economic journal “Capital” runs a cover story on Germany’s young elite featuring Andreas Kunze, CEO of MIG portfolio company Konux.

Funds for founders

Michael Motschmann, General Partner and member of the Executive Board at MIG AG, is quoted several times in an article by the Süddeutsche Zeitung on the funding options for start-up companies.

German biotechnology: foreign companies want in

The Handelsblatt has published an article shedding some light on the sale of MIG portfolio company Ganymed to Japanese pharmaceutical company Astellas. MIG is named as the venture capitalist.

Digital prize "The Spark" – More guts will do you good

Handelsblatt and McKinsey have awarded Konus and NaVvis, two portfolio companies of MIG Fonds, with the digital prize “The Spark” for innovations in industry 4.0.

We’re at the beginning of an era

Jürgen Eck, CEO of BRAIN AG, a MIG portfolio company, explains why he believes the trend for natural solutions in the chemical and consumer goods industry will keep on growing and growing.

Handelsblatt presents Efficient Energy, a MIG portfolio company, and describes their new refrigeration technology as an innovative breakthrough. MIG Fonds are named as venture capitalists.

Millions from California for the biotech pioneers from Mainz

Frankfurter Allgemeine Sonntagszeitung publishes an article about partnership between BioNTech, a MIG portfolio company, and the pharmaceutical company Genentech. Genentech has made an upfront payment of 310 million dollars to BioNTech.

Genentech lays $310M wager on BioNTech’s mRNA cancer vaccine platform

The trade journal FierceBiotech outlines the newest deal involving the payment of 310 million USD to MIG portfolio company BioNTech from Roche’s affiliated company Genentech.

Biontech deal sees Roche bet on mRNA

The article by EP Vantage covers the latest partnership entered into by MIG portfolio company BioNTech aiming to advance developments of mRNA-based cancer vaccines. The pharmaceutical group Roche is also in on the latest deal.

Interview with Michael Motschmann and Dr. Matthias Kromayer

The two MIG AG Executive Board members comment to recent successful exits, flotation of MIG portfolio company BRAIN and their next strategical moves with Venture Capital Magazin.

Inspiration in instalments

For a case study conducted by Harvard Business Manager, Dr. Matthias Kromayer, member of the Executive Board at MIG AG, discusses three principles of strategic company management.

The dream team of the biotech industry

Frankfurter Allgemeine Sonntagszeitung presents Özlem Türeci and Ugur Sahin, CEOs of Ganymed and BioNTech respectively. Both companies belong to the MIG portfolio.

Playing with your own money “kills your ego”

Profile of the MIG portfolio company Konux and its co-founder Andreas Kunze.

Billionaire-backed Ganymed grabs ASCO spotlight

The renowned trade journal FierceBiotech reports on ASCO, the largest oncology congress in the world. MIG portfolio company Ganymed is one of the stars of the show with their new phase 2b trial.

First universal cancer vaccine within reach

The article outlines MIG portfolio company BioNTech’s ground-breaking progress in the fight against cancer.

Off through the museum with a ‘data hoover’

FAZ has published a detailed article discussing how the 3D trolley developed by NavVis, an MIG portfolio company, captures and maps interior spaces.

Start-up company Konux – the defect detector

Smart sensors and prominent investors: MIG portfolio company Konux wants to revolutionise the untended German industry by helping to eliminate faults before they even occur.

An addition to the MIG Fonds portfolio

Finanzwelt talks about MIG Fonds‘ acquisition of a 16.26 % share in Konux Inc in a series A round, making Konux the youngest company in MIG’s portfolio.

China stumps up billions for German entrepreneurs

Heinrich von Pierer describes the latest trend, whereby Chinese sovereign wealth funds are ending up in Germany as venture capitalist funds – a development which can even create opportunities for MIG.

Cancer vaccines

Handelsblatt presents Biontech as an inspiring start-up business in the biotech sector in a full-page profile, making several references to MIG Fonds as the participating VC investor.

SZ features an article outlining the wide-reaching scope of the collaboration between Nfon, an MIG portfolio company, and German Telekom in developing cloud-based telephone systems.

NavVis, an MIG portfolio company, took pride of place as one of the hidden champions in an article listing over 50 successful digital business models.

Indoor satnavs

Handelsblatt has published an extensive profile on NavVis, citing MIG AG as a key VC investor who has been channeling money into the up-and-coming business since 2014.

Brain risks IPO despite the storm raging on the stock market

The response to being given the go-ahead for an IPO was obviously so good that the biotech firm Brain wants to follow through with its first steps onto the capital market despite the storm that’s currently raging.

Technological company Brain goes public

Dr. Heinrich von Pierer has written an article explaining what consequences the IPO of Brain AG, an MIG Fonds portfolio company, will have for the German start-up business scene.

Jury awards top-class prize to NavVis

This year, the internationally renowned DLD prize “Digital Star” goes to NavVis, an MIG Fonds portfolio company. The start-up company from Munich won the main prize entitled “Innovation of the Year”.

When Microorganisms solve problems

Börsen-Zeitung sheds some light on Brain AG’s business model, as well as their plans for the stock market. The article names MIG as an essential investor.